Elevated serum concentrations of the angiogenesis inhibitor endostatin in preeclamptic women

Journal of the Society for Gynecologic Investigation

Volumn 10, Issue 7, 2003, Pages 412-417

  Hirtenlehner, Kora ^a   Pollheimer, Jürgen ^a   Lichtenberger, Cornelia ^a   Wolschek, Markus F ^a   Zeisler, Harald ^a   Husslein, Peter ^a   Knöfler, Martin ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiogenesis; Endostatin; Preeclampsia; Serum

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOSTATIN;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; SOLUBILITY; STATISTICAL ANALYSIS; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; ENDOSTATINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; LOGISTIC MODELS; PRE-ECLAMPSIA; PREGNANCY; REFERENCE VALUES;

EID: 0141565206     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(03)00142-4     Document Type: Article

References (48)

1. Murphy S.L. Deaths Final data for 1998 . Natl Vital Stat Rep. 48:2000;1-105.
2. Meis P.J., Goldenberg R.L., Mercer B.M., et al. The preterm prediction study Risk factors for indicated preterm births . Am J Obstet Gynecol. 178:1998;562-567.
3. Roberts J.M., Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet. 357:2001;53-56.
4. Vedernikov Y., Saade G.R., Garfield R.E. Vascular reactivity in preeclampsia. Semin Perinatol. 23:1999;34-44.
5. Rodgers G.M., Taylor R.N., Roberts J.M. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol. 159:1999;908-914.
6. Matijevic R., Johnston T. In vivo assessment of failed trophoblastic invasion of spiral arteries in pre-eclampsia. Br J Obstet Gynaecol. 106:1999;78-82.
7. Pijnenborg R., Anthony J., Davey D.A., et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol. 98:1991;648-655.
8. Chua S., Wilkins T., Sargent I., Redman C. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol. 98:1991;973-979.
9. Seligman S.P., Buyon J.P., Clancy R.M., Young B.K., Abramson S.B. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol. 171:1994;944-948.
10. Wang Y., Walsh S.W., Kay H.H. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol. 167:1992;946-949.
11. Taylor R.N., Varma M., Teng N.N., Roberts J.M. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab. 71:1990;1675-1677.
12. Baker P.N., Krasnow J., Roberts J.M., Yeo K.T. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol. 86:1995;815-821.
13. VanWijk M.J., Kublickiene K., Boer K., VanBavel E. Vascular function in preeclampsia. Cardiovasc Res. 47:2000;38-48.
14. Svedas E., Islam K.B., Nisell H., Kublickiene K.R., Torry D.S., Wang H.S. Vascular endothelial growth factor induced functional and morphologic signs of endothelial dysfunction in isolated arteries from normal pregnant women. Am J Obstet Gynecol. 188:2003;168-176.
15. Wang T.H., Caudle M.R., Torry R.J. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol. 179:1998;1539-1544.
16. Page N.M., Woods R.J., Gardiner S.M., et al. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature. 405:2000;797-800.
17. Smarason A.K., Sargent I.L., Redman C.W. Endothelial cell proliferation is suppressed by plasma but not serum from women with preeclampsia. Am J Obstet Gynecol. 174:1996;787-793.
18. Smarason A.K., Sargent I.L., Starkey P.M., Redman C.W. The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol. 100:1993;943-949.
19. Ortega N., Werb Z. New functional roles for non-collagenous domains of basement membrane collagens. J Cell Sci. 115:2002;4201-4214.
20. O'Reilly M.S., Boehm T., Shing Y., et al. Endostatin An endogenous inhibitor of angiogenesis and tumor growth . Cell. 88:1997;277-285.
21. Hanai J., Dhanabal M., Karumanchi S.A., et al. Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J Biol Chem. 277:2002;16464-16469.
22. Karihaloo A., Karumanchi S.A., Barasch J., et al. Endostatin regulates branching morphogenesis of renal epithelial cells and ureteric bud. Proc Natl Acad Sci U S A. 98:2001;12509-12514.
23. Yamaguchi N., Anand-Apte B., Lee M., et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J. 18:1999;4414-4423.
24. Knöfler M., Saleh L., Bauer S., et al. Promoter elements and transcription factors involved in differentiation-dependent human chorionic gonadotrophin-alpha messenger ribonucleic acid expression of term villous trophoblast. Endocrinology. 141:2000;3737-3748.
25. Halligan A., Bonnar J., Sheppard B., Darling M., Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol. 101:1994;488-492.
26. He S., Silveira A., Hamsten A., Blomback M., Bremme K. Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia. Thromb Haemost. 81:1999;538-542.
27. Kim Y.M., Hwang S., Kim Y.M., et al. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem. 277:2002;27872-27879.
28. Dhar D.K., Ono T., Yamanoi A., et al. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma. Cancer. 95:2002;2188-2195.
29. Asai K., Kanazawa H., Otani K., Shiraishi S., Hirata K., Yoshikawa J. Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects. J Allergy Clin Immunol. 110:2002;571-575.
30. Robak E., Wozniacka A., Sysa-Jedrzejowska A., Stepien H., Robak T. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus. Lupus. 11:2002;348-355.
31. Nagashima M., Asano G., Yoshino S. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis. J Rheumatol. 27:2000;2339-2342.
32. Sasaki T., Hohenester E., Timpl R. Structure and function of collagen-derived endostatin inhibitors of angiogenesis. J Int Un Biochem Mol Biol. 53:2002;77-84.
33. Feldman A.L., Tamarkin L., Paciotti G.F., et al. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer. Clin Cancer Res. 6:2000;4628-4634.
34. Morimoto T., Aoyagi M., Tamaki M., et al. Increased levels of tissue endostatin in human malignant gliomas. Clin Cancer Res. 8:2002;2933-2938.
35. Ergun S., Kilic N., Wurmbach J.H., et al. Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes. Angiogenesis. 4:2001;193-206.
36. Wen W., Moses M.A., Wiederschain D., Arbiser J.L., Folkman J. The generation of endostatin is mediated by elastase. Cancer Res. 59:1999;6052-6056.
37. Saarela J., Rehn M., Oikarinen A., Autio-Harmainen H., Pihlajaniemi T. The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am J Pathol. 153:1998;611-626.
38. Ma L., Elliott S.N., Cirino G., Buret A., Ignarro L.J., Wallace J.L. Platelets modulate gastric ulcer healing Role of endostatin and vascular endothelial growth factor release . Proc Natl Acad Sci U S A. 98:2001;6470-6475.
39. Rein D.T., Schondorf T., Gohring U.J., et al. Cytokine expression in peripheral blood lymphocytes indicates a switch to T(HELPER) cells in patients with preeclampsia. J Reprod Immunol. 54:2002;133-142.
40. Saito S., Umekage H., Sakamoto Y., et al. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol. 415:1999;297-306.
41. Wang P., Ba Z.F., Chaudry I.H. Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. Am J Physiol. 266:1994;2535-2541.
42. Maynard S.E., Min J.Y., Merchan J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 111:2003;649-658.
43. Koga K., Osuga Y., Yoshino O., et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab. 88:2003;2348-2351.
44. Hanai J., Dhanabal M., Karumanchi S.A., et al. Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J Biol Chem. 277:2002;16464-16469.
45. Hanai J., Gloy J., Karumanchi S.A., et al. Endostatin is a potential inhibitor of Wnt signaling. J Cell Biol. 58:2002;529-539.
46. Athanassiades A., Hamilton G.S., Lala P.K. Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol Reprod. 59:1998;643-654.
47. Zhou Y., McMaster M., Woo K., et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 160:2002;1405-1423.
48. DiFederico E., Genbacev O., Fisher S.J. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol. 155:1999;293-301.